You are here:Home-Chemical Inhibitors & Agonists-Ras-Raf-MAPK-ERK Pathway-MEK (MAP2K)-Trametinib DMSO solvate
Trametinib DMSO solvate

Chemical Structure : Trametinib DMSO solvate

CAS No.: 1187431-43-1

Trametinib DMSO solvate (GSK-1120212 DMSO solvate;Trametinib;JTP-74057;GSK-1120212;GSK1120212;GSK 1120212;JTP 74057;JTP74057)

Catalog No.: PC-42775Not For Human Use, Lab Use Only.

A potent and highly specific MEK1/2 inhibitor with IC50 of 0.92 nM/1.8 nM.

Packing Price Stock Quantity
50 mg $64 In stock
100 mg $95.2 In stock

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

A potent and highly specific MEK1/2 inhibitor with IC50 of 0.92 nM/1.8 nM; exhibits no inhibition on the kinase activities of c-Raf, B-Raf, ERK1/2.

Skin Cancer

Approved

Physicochemical Properties

M.Wt 693.5283
Formula C28H29FIN5O5S
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

DMSO: ≥ 69 mg/mL (Need ultrasonic)

Chemical Name/SMILES

N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide compound with (methylsulfinyl)methane (1:1)

References

1. Gilmartin AG, et al. Clin Cancer Res. 2011 Mar 1;17(5):989-1000.

2. Flaherty KT, et al. N Engl J Med. 2012 Nov 1;367(18):1694-703.

3. Yamaguchi T, et al. Int J Oncol, 2011, 39(1), 23-31.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: